Malabsorption in psoriatic patients: Cause or consequence?

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 11, 2006, Pages 1267-1271

  Ojetti, Veronica ^a   De Simone, Clara ^a   Sanchez, Jose Aguilar ^a   Capizzi, Rodolfo ^a   Migneco, Alessio ^a   Guerriero, Cristina ^a   Cazzato, Alessia ^a   Gasbarrini, Giovanni ^a   Amerio, Pierluigi ^a   Gasbarrini, Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bacterial overgrowth; Coeliac disease; Eosinophilic gastritis; Malabsorption; Parasites; Psoriasis

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; LACTULOSE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; ARTICLE; BACTERIAL GROWTH; BREATH ANALYSIS; COLONOSCOPY; CONTROLLED STUDY; EOSINOPHILIC GASTROENTERITIS; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCREENING TEST; XYLOSE TEST;

ADULT; CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; GASTRITIS; HUMANS; INTESTINAL DISEASES, PARASITIC; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; ROME; XYLOSE;

EID: 33750394664     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600633529     Document Type: Article

References (35)

1. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005;5: 699-711.
2. Tagami H. Triggering factors. Clin Dermatol 1997;15:677-85.
3. Christophers E. Psoriasis: epidemiology and clinical spectrum. Clin Exp Dermatol 2001;26:314-20.
4. Mendonca CO, Burden AD. Current concepts in psoriasis and its treatment. Pharmacol Ther 2003;99:133-47.
5. Mcmillin DL, Richards DG, Mein EA, Nelson CD. Systemic aspects of psoriasis. An integrative model based on intestinal etiology. Integr Med 2000;21(2):105-13.
6. Lee F, Bellary S, Francis C. Increased occurrence of psoriasis in patients with Crohn's and their relatives. Am J Gastroenterol 1990;85:962-3.
7. Oh C, Das KM, Gottlieb AB. Treatment with anti-tumor necrosis factor alpha monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J Am Acad Dermatol 2000;42:829-30.
8. Michaelsson G, Gerden B. How common is gluten intolerance among patients with psoriasis? Acta Derm Venereol (Stockh) 1991;71:9.
9. Basex A, Gaillet L, Basex J. Gluten-free diet and psoriasis. Ann Dermatol Syphiligr 1976;103:648-50.
10. Cottafava F, Cosso D. Psoriatic arthritis and celiac disease in childhood. A case report. Pediatr Med Chir 1991;13:431-3.
11. Nair RP, Henseler T, Jenisch S, Stuart T, Bichakjian CK, Lenk W, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997;6:1349-56.
12. Michaelsson G, Kraaz W, Hagforsen E, Pihl-Lundin I, Loof L, Scheynius A. The skin and the gut in psoriasis: the number of mast cells and CD3+ lymphocytes is increased in non-involved skin and correlated to the number of intraepithelial lymphocytes and mast cells in the duodenum. Acta Derm Venereol 1997;77(5):343-6.
13. Khardikova SA, Nepomnyaschikh GI, Aidagulova SV, Lapii GA. Ultrastructural characteristics of cell populations in the gastric and duodenal mucosa during psoriasis. Bull Exp Biol Med 2002;134:489-92.
14. Michaelsson G, Kraaz W, Hagforsen E, Pihl-Lundin I, Loof L. Psoriasis patients have highly increased numbers of tryptase-positive mast cells in the duodenal stroma. Br J Dermatol 1997;136:866-70.
15. Michaelsson G, Kraaz W, Gerden B, Hagforsen E, Lundin IP, Loof L, et al. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma. Br J Dermatol 1996;135:371-8.
16. Oxentenko AS, Murray JA. Celiac disease and dermatitis herpetiformis: the spectrum of gluten-sensitive enteropathy. Int J Dermatol 2003;42:585-7.
17. Michaelsson G, Gerden B, Hagforsen E, Nilsson B, Pihl-Lundin I, Kraaz W, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 2000;142:44-5.
18. Addolorato G, Parente A, De Lorenzi G, D'Angelo Di Paola ME, Abenavoli L, et al. Rapid regression of psoriasis in a coeliac patient after gluten-free diet. Digestion 2003;68:9-12.
19. Lindqvist U, Rudsander A, Bostrom A, Nilsson B, Michaelsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology 2002;4:31-7.
20. Ojetti V, Aguilar Sanchez J, Guerriero C, Fossati B, Capizzi R, De Simone C, et al. High prevalence of celiac disease in psoriasis. Am J Gastroenterol 2003;98:2574-5.
21. Craig RM, Ehrenpreis ED. D-xylose testing. J Clin Gastroenterol 1999;29:143-50.
22. Ehrenpreis ED, Salvino M, Craig RM. Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol 2001;33:36-40.
23. Harewood GC, Holub JL, Lieberman DA. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am J Gastroenterol 2004;99:1790-4.
24. Bailliers. Modified Marsh classification. Clin Gastroenterol 1995;9:273-93.
25. Corazza GR, Sorge M, Strocchi A, Benati G, Di Sario A, Treggiani E, et al. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol 1992;24 Suppl 2:4-9.
26. Prinz JC. The role of T cells in psoriasis. J Eur Acad Dermatol Venerol 2003;17:257-70.
27. Salvati VM, MacDonald TT, Bajaj-Elliott M, Borrelli M, Staiano A, Auricchio S, et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002;50:186-90.
28. Anantharaju A, Klamut M. Small intestinal bacterial overgrowth: a possible risk factor for metabolic bone disease. Nutr Rev 2003;61:132-5.
29. Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Gastroenterol Rep 2003;5:365-72.
30. Leder K, Weller P. Giardiasis. In: Rose BD, editor. Infectious disease. Wellesley, Mass: UpToDate; 2002.
31. Katz DE, Taylor DN. Parasitic infections of the gastrointestinal tract. Gastroenterol Clin North Am 2001;30:795-815.
32. Faubert G. Immune response to Guardia duodenalis. Clin Microbiol Rev 200;13:35-54.
33. Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004;113:11-28.
34. Straumann A, Simon HU. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 2004;59:15-25.
35. Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol 1997;32: 556-63.